Metformin Mitigates Hemodynamic, Autonomic, Oxidative, and Inflammatory Dysregulation in L-NAME-Induced Preeclampsia.

Afghan S, Quasimi H, Alam MI, Wazib S, Ambardar Y, Gautam S.

Open source

DOI
10.2174/0113816128463168260724045843
Published
2026-08-03
Container
Curr Pharm Des
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113816128463168260724045843,
  title = {Metformin Mitigates Hemodynamic, Autonomic, Oxidative, and Inflammatory Dysregulation in L-NAME-Induced Preeclampsia.},
  author = {Afghan S and  Quasimi H and  Alam MI and  Wazib S and  Ambardar Y and  Gautam S.},
  year = {2026},
  journal = {Curr Pharm Des},
  doi = {10.2174/0113816128463168260724045843},
  url = {https://doi.org/10.2174/0113816128463168260724045843}
}

RIS

TY  - JOUR
TI  - Metformin Mitigates Hemodynamic, Autonomic, Oxidative, and Inflammatory Dysregulation in L-NAME-Induced Preeclampsia.
AU  - Afghan S
AU  -  Quasimi H
AU  -  Alam MI
AU  -  Wazib S
AU  -  Ambardar Y
AU  -  Gautam S.
PY  - 2026
JO  - Curr Pharm Des
DO  - 10.2174/0113816128463168260724045843
UR  - https://doi.org/10.2174/0113816128463168260724045843
ER  - 

APA

S, A., H, Q., MI, A., S, W., Y, A., & S., G. (2026). Metformin Mitigates Hemodynamic, Autonomic, Oxidative, and Inflammatory Dysregulation in L-NAME-Induced Preeclampsia.. Curr Pharm Des. https://doi.org/10.2174/0113816128463168260724045843

Source records